Ad is loading...
MENU

PHAT Phathom Pharmaceuticals Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
PHAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PHAT is expected to report earnings to -130 cents per share on March 04

Phathom Pharmaceuticals PHAT Stock Earnings Reports
Q4'24
Est.
$-1.31
Q3'24
Beat
by $0.15
Q2'24
Missed
by $0.24
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.27
The last earnings report on November 07 showed earnings per share of -132 cents, beating the estimate of -147 cents. With 2.16M shares outstanding, the current market capitalization sits at 600.35M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIKJX18.61-0.01
-0.05%
Fidelity Advisor Real Estate Z
GACIX47.39-0.30
-0.63%
Gabelli Small Cap Growth I
FTGQX26.66-0.24
-0.89%
Templeton Growth C
MFQAX18.52-0.21
-1.12%
AMG Veritas Global Focus N
VTAIX11.92-0.14
-1.16%
Virtus Tactical Allocation I

PHAT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with VERA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then VERA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-3.41%
VERA - PHAT
43%
Loosely correlated
-5.59%
TNFA - PHAT
39%
Loosely correlated
-2.75%
ATRA - PHAT
36%
Loosely correlated
-6.03%
AKRO - PHAT
32%
Poorly correlated
-5.61%
ALDX - PHAT
32%
Poorly correlated
-1.41%
More